ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar 20100626 (< 20) Submitted: 7/17/2010 12:32:40 PM : Outperform Start Price: $10.91 VPHM Score: +61.02

Bravobevo

Featured Broker Partners


Advertisement